Intraoperative MRI Market: Soaring to USD 2.77 Billion by 2035 with 8.5% CAGR

Analysis of Intraoperative MRI Equipment Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

The intraoperative MRI (iMRI) equipment market is projected to reach a valuation of USD 1,220 million by 2025, according to research by Fact.MR. Driven by a compound annual growth rate (CAGR) of 8.5%, the market is expected to expand significantly, reaching USD 2,770 million by 2035. This growth is primarily fueled by the increasing prevalence of complex neurosurgical procedures that demand real-time, high-precision imaging—a capability uniquely offered by intraoperative MRI systems.

Rising investments by hospitals in advanced imaging suites, along with the broader shift toward minimally invasive surgical techniques, are accelerating demand for high-performance diagnostic tools like iMRI. These systems have become essential in modern operating rooms, particularly in neurology and oncology departments, where intraoperative visualization directly enhances surgical accuracy and patient safety.

iMRI equipment enables surgeons to obtain updated imaging during procedures, allowing for precise navigation and immediate adjustments. This not only enhances procedural success but also reduces the risk of reoperations and improves overall patient outcomes. As a result, more hospitals and surgical centers are integrating iMRI systems into their operating theaters to support real-time, data-driven clinical decisions.

For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=519

Technological advancements are also playing a pivotal role in market expansion. The development of compact, low-field MRI systems has made intraoperative imaging more accessible to mid-sized and regional hospitals by reducing infrastructure requirements and enhancing flexibility. These newer-generation systems offer improved image quality and are increasingly used in conjunction with robotic-assisted surgical procedures, which are becoming standard in leading healthcare institutions.

Regionally, North America continues to dominate the market, supported by robust healthcare spending and early adoption of image-guided surgical technologies. However, the Asia-Pacific region is rapidly emerging as a high-growth market. Nations like China, India, and South Korea are actively modernizing hospital infrastructure, with a strong emphasis on improving surgical precision and postoperative outcomes—factors that make iMRI systems a strategic priority in regional healthcare planning.

Looking ahead, the focus for industry stakeholders will likely shift toward further miniaturization of systems, cost optimization, and seamless integration with digital surgery platforms. As global surgical volumes rise, intraoperative MRI is poised to transition from a niche innovation to a standard feature in operating rooms worldwide. The future of this technology lies not only in its clinical sophistication but also in its ability to scale across diverse healthcare environments, delivering tangible benefits in patient care and operational efficiency.

.​Key Market Drivers

1. Technological Advancements: The development of miniaturized, low-field MRI systems has made it feasible for a broader range of hospitals to adopt iMRI technology. These systems require less infrastructural investment and offer improved flexibility and image quality.​
2. Rising Demand for Precision Surgery: The increasing complexity of surgical procedures necessitates real-time imaging to ensure accuracy. iMRI systems fulfill this need, particularly in neurosurgical interventions where precision is critical.​
3. Healthcare Infrastructure Expansion: Emerging markets in Asia-Pacific, Latin America, and Africa are investing in healthcare infrastructure, creating opportunities for the adoption of advanced surgical technologies like iMRI

Market Segmentation

By Product Type:

• 0.2T Systems: These low-field systems are gaining popularity due to their reduced risk of geometrical distortion and suitability for less complex procedures. In 2017, approximately 1,275 units were sold globally
• 1.5T Systems: Offering a balance between image quality and cost, these systems are widely used in various surgical applications.​
• 3.0T Systems: High-field systems are preferred for complex neurosurgical procedures due to their superior image resolution. The demand for these systems is expected to grow at a CAGR of 9% over the forecast period

By Application:

• Neurosurgical Interventions: Accounting for over 30% of the market volume, iMRI is extensively used in brain surgeries to enhance precision and outcomes
• Orthopedic Procedures: The prevalence of orthopedic disorders requiring high-field MRI scanning is driving the adoption of iMRI in this segment.​
• Cardiovascular Interventions: Though currently a smaller segment, the use of iMRI in cardiovascular surgeries is anticipated to grow with technological advancements.​

By End User:

• Hospitals: Representing approximately 40% of the market volume, hospitals are the primary adopters of iMRI systems, integrating them into advanced operating suites
• Cancer Research Institutes: These institutions utilize iMRI for precise tumor localization and real-time monitoring during oncological surgeries.​
• Academic Institutes: Used for research and training purposes, academic institutes are incorporating iMRI to advance surgical education and innovation.​

Regional Insights

• North America: Leading the market due to high healthcare spending and early adoption of advanced surgical technologies. Approximately 75% of hospitals prioritize full-suite hybrid operating rooms, combining iMRI with robotic and navigation technologies
• Europe: Focuses on optimizing surgical throughput with faster scan-to-surgery transitions to minimize operating room time. About 79% of European hospitals emphasize this efficiency
• Asia-Pacific: Emerging as a significant market with countries like China, India, and South Korea investing in hospital modernization. Approximately 66% of hospitals in this region are upgrading infrastructure to support intraoperative imaging

Competitive Landscape

The iMRI equipment market is characterized by the presence of key players focusing on innovation and strategic partnerships to enhance their market position. Major companies include:​

• GE Healthcare
• Medtronic Plc
• Siemens AG
• IMRIS Inc.
• Koninklijke Philips N.V.
• Hitachi Corporation

These companies are investing in research and development to produce more efficient, cost-effective, and compact iMRI systems to cater to a broader customer base

Get Customization on this Report for Specific Research Solutions: https://www.factmr.com/connectus/sample?flag=S&rep_id=519

Future Outlook

The intraoperative MRI equipment market is set to experience robust growth, driven by technological advancements, increasing demand for precision in surgeries, and the expansion of healthcare infrastructure globally. The integration of iMRI into surgical practices enhances patient outcomes and operational efficiency, making it an essential component of modern healthcare facilities. As the technology becomes more accessible and affordable, its adoption is expected to become widespread, transforming surgical procedures and patient care worldwide.​

Explore More Related Studies Published by Fact.MR Research:

The valuation of the global physical therapy services market is set to reach US$ 131.4 million in 2024 and climb to US$ 192.2 million by the end of 2034. The market has been thoroughly analyzed to expand at a 3.9% CAGR from 2024 to 2034, according to this new research study by Fact.MR, a marketing intelligence provider.

The global cancer immunotherapy market is set to garner US$ 159.2 billion in revenue in 2024, according to Fact.MR, a market research and intelligence provider. Worldwide demand for cancer immunotherapies is projected to increase at a CAGR of 10% and reach a market value of US$ 412.8 billion by 2034.

The global robotic surgery market size is set to be valued at US$ 5.12 billion in 2024 and is forecasted to expand at a remarkable CAGR of 11.7% to reach US$ 15.52 billion by the end of 2034.

Worldwide revenue from the sales of Treponema pallidum test kits is expected to reach US$ 204.6 million in 2024. The global Treponema pallidum test market is analyzed to climb to a value of US$ 360 million by the end of 2034, expanding at a CAGR of 5.8%.

The global progressive multifocal leukoencephalopathy treatment market size is calculated to reach a valuation of US$ 143.3 million in 2024 and thereafter expand at a CAGR of 2.7% to end up at US$ 187.3 million by 2034.